Pharma M&A Integration

Engaged by one of the world’s leading pharmaceutical firms to lead integration programs for several high profile acquisitions. Worked closely with client teams and the acquired firms to implement a portfolio of merger integration projects designed to maximize the realized value and minimize the risk of these acquisitions. These engagements enabled the client to maintain business continuity; secure intellectual property; transition personnel; integrate research, development and business systems and data; complete site closures across North America and Europe; and execute related divestitures. These engagements were highly acclaimed by client management and resulted in effective integration and significant costs savings compared to previous acquisition integration efforts.